Community Oncology Alliance pushing alternative to pricing index for Part B drugs

The Community Oncology Alliance is in discussions with congressional staff and the Trump administration about modifying the existing Medicare Part B payment structure as an alternative to the International Pricing Index that HHS Secretary Alex Azar has proposed for Part B drugs.

In comments submitted to CMS in December 2018, COA, a politically potent organization that represents community oncology practices, suggested the establishment of a “tiered structure for brands whereby higher priced brands have a lower add-on payment and the add-on payment increases as the brand price is lower.”...